Informational informed consent
INFORMATIONAL INFORMED CONSENT
ORAL (ENTERAL) SEDATION
ORAL OR ENTERAL SEDATION
is made available by this office to assist in minimizing anxiety that may be associated with
going to the dentist. The intent of oral sedatives is to relax you yet still enable you to communicate with the dentist while
treatment is being performed. Even though oral sedation is safe, effective and generally free of complications, by reading and
signing this form, you acknowledge that you are aware of possible risks of oral sedation, acknowledge these risks, and consent
to and accept the option of receiving oral sedation. 1
. I acknowledge that I have read and signed this Informational Informed Consent form
prior to my taking any form of oral
sedation. I acknowledge that some oral sedatives are generally prescribed as sleeping pills but are safely used in conjunction with dental procedures to decrease anxiety.
2. I agree not to drive to or from the office after taking any sedative medication
, and I understand that I am responsible for
arranging for my own transportation to and from the dental office. I also agree not to drive or operate any machinery for the remainder of the day of treatment. I agree to have someone stay with me for several hours after sedation due to possible disorientation and to prevent possible injury from falling due to disorientation, loss of balance, etc.
3. I agree to inform the office and refrain from undergoing oral sedation if the following conditions are present
A. Hypersensitivity to benzodiazepine drugs (Valium, Ativan, Versed)
4. I have disclosed to the dentist that I am taking any of the following drugs
that may adversely react with oral sedatives:
Nefazodone (Serzone); cimetidine (tagamet, tagamet HB, Novocimetine, Peptol); levodopa (Dopar or Larodopa) for Parkinson's Disease; antihistamines such as Benedryl or Tavist); verapamil (Calan); diltiazem (Cardizem); Erythromycin and the azole antimycotic class of drugs (Biaxin, Nizoral or Sporanox); HIV treatment drugs (indinavir and nelfinovar; alcohol; any recreational/illicit drugs.
5. Side effects
may include light-headedness, headache, dizziness, visual disturbances, amnesia, nausea or allergic reactions.
Rarely, these side effects may require medical attention or hospitalization. With some patients, especially smokers, oral sedatives do not provide the desired anti-anxiety effects; therefore, planned dental procedures may need to be postponed or terminated.
6. Complications may ensue if instructions
of not eating or drinking for a specified interval prior to the dental appointment
7. The onset of many oral sedatives is usually 15 to 30 minutes
and the peak effect generally occurs between one and two
hours. Effects of the drug are generally almost completely diminished after six to eight hours. In extreme cases, some patients sustain substantial or severe respiratory depression or the need for hospitalization and in very rare cases, possible cardiac arrest or death. Therefore, it is essential to notify the dentist immediately of any untoward reactions or delayed recovery following the procedure.
8. I consent to the use of nitrous oxide (laughing gas) in conjunction with oral sedation
as well as local anesthetic. 9
. I authorize the dentist to use his/her best judgment in managing unforeseen conditions
which might unexpectedly
arise during the course of oral sedation and the planned dental procedures. I acknowledge that lack of cooperation with recommendations made concerning dosage and other protocols associated with oral sedation may contribute to less than desired results.
I have been given the opportunity to ask any questions regarding the nature and purpose of oral or enteral sedation
and have received answers to my satisfaction. I acknowledge that oral sedation is an option and not absolutely necessary for dental treatment
but, nevertheless, I accept this option. I do voluntarily assume any and all possible risks including, but not necessarily limited to those listed
above, including risk or substantial harm or even death, which may be associated with oral sedative drugs. I acknowledge that planned
treatment may be postponed or terminated if oral sedative drugs do not provide the desired effect, and I acknowledge that no guarantees or
promises have been made to me concerning the efficacy of oral sedation in my case or the case of my minor child or ward for whom I give
consent for this procedure. The fees for oral sedation have been explained to me and are satisfactory. By signing this document I am freely
giving my consent to allow and auth and/or his/her associates or agents to render oral sedation as
deemed appropriate and/or advisable to my dental condition, including prescribing and administering appropriate anesthetics and/or
Wealthlink Financial Group Inc. – Fillable Form MEDICAL DECLARATION – Version V05 Instructions: a) Complete for any applicant age 60 to 85 who is applying for the Stable Chronic Condition Option. b) Complete for all applicants age 86 or over. c) Agent must fax to 1-866-285-5727 or mail to 21st Century within 3 business days of making sale. Agency Name ____________________________
EMBARGOED FOR RELEASE UNTIL 14.30 (CEST) ON 27 JUNE Contact: Kara Dress: +1-202-367-2434, 25-29 June: ECTS-IBMS Media Room, Secretariat 1 Palexpo Congress Centre, Geneva, Switzerland SPORADIC STEROID USE DOES NOT INCREASE BONE FRACTURE RISK Geneva, Switzerland (27 June 2005)—Research has shown that prolonged use of oral steroids is linked to osteoporosis and an increased risk